"Adult" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
| Descriptor ID |
D000328
|
| MeSH Number(s) |
M01.060.116
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adult".
Below are MeSH descriptors whose meaning is more specific than "Adult".
This graph shows the total number of publications written about "Adult" by people in this website by year, and whether "Adult" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 243 | 243 |
| 1997 | 0 | 298 | 298 |
| 1998 | 0 | 281 | 281 |
| 1999 | 0 | 291 | 291 |
| 2000 | 0 | 298 | 298 |
| 2001 | 0 | 362 | 362 |
| 2002 | 0 | 395 | 395 |
| 2003 | 0 | 493 | 493 |
| 2004 | 0 | 518 | 518 |
| 2005 | 0 | 531 | 531 |
| 2006 | 0 | 518 | 518 |
| 2007 | 0 | 588 | 588 |
| 2008 | 0 | 555 | 555 |
| 2009 | 0 | 625 | 625 |
| 2010 | 0 | 698 | 698 |
| 2011 | 0 | 729 | 729 |
| 2012 | 0 | 848 | 848 |
| 2013 | 0 | 953 | 953 |
| 2014 | 0 | 981 | 981 |
| 2015 | 0 | 1084 | 1084 |
| 2016 | 0 | 1109 | 1109 |
| 2017 | 0 | 1134 | 1134 |
| 2018 | 0 | 1263 | 1263 |
| 2019 | 0 | 1123 | 1123 |
| 2020 | 0 | 1111 | 1111 |
| 2021 | 0 | 946 | 946 |
| 2022 | 0 | 596 | 596 |
| 2023 | 0 | 558 | 558 |
| 2024 | 0 | 1183 | 1183 |
| 2025 | 0 | 889 | 889 |
| 2026 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adult" by people in Profiles.
-
Genetic Risk and Transition Through Preclinical Stages of Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e493-e499.
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i39-i45.
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) in Adults, Children, and Pregnant People. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i33-i38.
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) and Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i27-i32.
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i1-i5.
-
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 years. Blood Adv. 2026 Jan 13; 10(1):168-180.
-
Genome-wide gene by sleepiness interaction analysis for sleep apnea. Sleep. 2026 Jan 13; 49(1).
-
Multicenter analysis of flow diversion for recurrent/persistent intracranial aneurysms after stent-assisted coiling. J Neurointerv Surg. 2026 Jan 13; 18(2):324-331.
-
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv. 2026 Jan 13; 10(1):217-227.
-
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up. Am J Epidemiol. 2026 Jan 08; 195(1):168-177.